Purchase Order 36C25624P0339
- Not listed
- Boston Scientific Corp has been awarded a delivery order valued at $661,095 for TheraSphere Y-90, a radiation treatment device, by the Department of Veterans Affairs through Veterans Integrated Service Network 22. This firm fixed-price contract, with an ultimate completion date of December 17, 2026, is being performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. The award was issued on December 18, 2025, and no set-aside designation was utilized in this...
- Boston Scientific Corp has been awarded a delivery order valued at $4.06M for TheraSphere Yttrium-90 Glass, a specialized radiation treatment device, by Veterans Integrated Service Network 6 (VISN 6), a civilian healthcare network within the Department of Veterans Affairs. The contract, awarded on April 1, 2024, operates under a firm fixed-price delivery order structure with an ultimate completion date of December 31, 2028. The award carries no set-aside designation, indicating Boston Scientific...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a purchase order by Veterans Integrated Service Network 17 (VISN 17), under the Department of Veterans Affairs, for Y90 Glass Microspheres with a ceiling value of $4.64M. The contract is a firm fixed-price purchase order with an ultimate completion date of December 12, 2025, and was awarded on April 23, 2022. The place of performance is Boston Scientific's Marlborough,...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a $397,000 firm fixed-price delivery order to Boston Scientific Corp for TheraSphere Y-90, a yttrium-90 glass radiation treatment device used in interventional oncology procedures. The contract, awarded on October 1, 2025, with a completion date of September 30, 2026, represents a non-set-aside competitive award to the Marlborough, Massachusetts-based medical device manufacturer. Boston...
- Boston Scientific Corp has been awarded a purchase order valued at $56,545.00 for the deobligation of fiscal year 2025 funds related to TheraSphere Y90 Glass Microspheres, a specialized radiation treatment device used in interventional oncology. The contract, awarded on October 4, 2024, with an ultimate completion date of September 30, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 22, awarded a delivery order contract to Boston Scientific Corp on October 1, 2024, for the supply of TheraSphere Yttrium-90 Glass, a specialized radiation treatment device. The contract, valued at $279,420 with a firm fixed price structure, is scheduled for completion by September 30, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order was issued under...
- Boston Scientific Corp has been awarded a delivery order valued at $518,712 for Yttrium-90 (Y-90) TheraSphere, a specialized radiation treatment device used in oncology applications. The contract is a firm fixed-price delivery order with an ultimate completion date of December 31, 2026, issued without a small business set-aside. The award was made by Veterans Integrated Service Network 6, a component of the Department of Veterans Affairs, with performance taking place in Richmond, Virginia. This...
- Boston Scientific Corporation, doing business as Boston Scientific, was awarded a $89,975 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The award is for the delivery of TheraSphere Y-90 radioactive microspheres to support interventional radiology treatment services through September 2023. No set aside designation was indicated. Boston Scientific holds an existing indefinite delivery contract with the...
- Boston Scientific Corporation, doing business as Boston Scientific, has been awarded a $89,730 firm fixed price purchase order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to provide TheraSphere Y-90 glass microspheres. The place of performance is in Marlborough, Massachusetts and the period of performance concludes on September 30, 2023. No set-aside designation was applied to this procurement. The TheraSphere Y-90 radioactive...
- Boston Scientific Corporation, doing business as Boston Scientific, has been awarded a $477,415 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. This delivery order is issued against Boston Scientific's existing indefinite delivery contract with the VA worth up to $295 million over five years to provide surgical implants and related services. The current award is to supply Yttrium-90 glass...
Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a firm fixed-price purchase order valued at $2.47M by Veterans Integrated Service Network (VISN) 16 for Y90 TheraSphere radiation treatment devices. The contract, awarded January 1, 2024, with an ultimate completion date of September 30, 2028, represents a direct award with no small business set-aside. As a leading global medical technology company, Boston Scientific supplies specialized radiation oncology equipment and yttrium-90 glass microspheres to support cancer treatment capabilities across the Veterans Affairs healthcare system. The award reflects the Department of Veterans Affairs' reliance on Boston Scientific's proven expertise in delivering complex, specialized medical devices for oncology applications. This purchase order award aligns with Boston Scientific's broader role as a critical supplier of radiation treatment technologies to federal healthcare agencies. The company maintains an established Blanket Purchase Agreement with the Defense Health Agency valued at $750K for radiation treatment devices, demonstrating the federal government's confidence in Boston Scientific's capability to maintain consistent supply chain support for specialized cancer treatment modalities. The VISN 16 award enables rapid procurement of Y90 TheraSphere products to support oncology services at Veterans Affairs medical facilities, ensuring continuity of access to this advanced therapeutic technology for eligible veteran patients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Funding Only Action | ($19k) | 2/9/26 | |
| P00005 | Funding Only Action | $315.0k | 10/1/25 | |
| P00004 | Exercise an Option | $0 | 9/22/25 | |
| P00003 | Other Administrative Action | $300.0k | 10/8/24 | |
| P00002 | Exercise an Option | $300.0k | 10/1/24 |